Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 7,850.00
0.00 (0.00%)
At close: Feb 19, 2026
Wonbiogen Market Cap
Wonbiogen has a market cap or net worth of 53.91 billion as of February 20, 2026. Its market cap has increased by 32.38% in one year.
Market Cap
53.91B
Enterprise Value
40.44B
Revenue
34.38B
Ranking
n/a
PE Ratio
8.17
Stock Price
7,850.00
Market Cap Chart
Since January 26, 2021, Wonbiogen's market cap has increased from 47.59B to 53.91B, an increase of 13.27%. That is a compound annual growth rate of 2.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 55.68B | 17.51% |
| Dec 30, 2025 | 47.38B | 16.35% |
| Dec 30, 2024 | 40.72B | -32.55% |
| Dec 28, 2023 | 60.37B | 3.39% |
| Dec 29, 2022 | 58.40B | -21.09% |
| Dec 30, 2021 | 74.00B | 55.49% |
| Jan 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CG MedTech | 194.75B |
| T&R Biofab | 149.37B |
| OSTEONIC | 132.60B |
| JW Shinyak | 121.24B |
| Sewoon Medical | 111.91B |
| SCL Science | 73.99B |
| KM Corporation | 47.28B |
| MEDYSSEY Co.,Ltd | 43.44B |